NO-releasing hybrid6regulates colon cancer-related signaling pathways, exhibiting potent anti-colon cancer activityin vitroandin vivo.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: